[On the effect of paraoxon on the electrical activity of efferent cervical sympathetic nerves and the blood pressure of rats].
D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D001532:Atropa belladonna / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002490:Central Nervous System / Q000502:physiology; D002800:Cholinesterase Inhibitors / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D003864:Depression, Chemical; D008297:Male; D010091:Oximes / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010710:Phosphates / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011220:Pralidoxime Compounds / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D014666:Vasomotor System / Q000502:physiology
D002800:Cholinesterase Inhibitors; D010091:Oximes; D010710:Phosphates; D011220:Pralidoxime Compounds; D011725:Pyridines; D001285:Atropine; D012110:Reserpine; D010646:Phentolamine
Uber die Wirkung von Paraoxon auf die elektrische Aktivität des efferenten Halssympathicus und den Blutdruck der Ratte.